Drug Trial Radar · NCT01058174
Liver Transplant European Study Into the Prevention of Fungal Infection
Last checked: Nov 19, 2026Latest source record: Nov 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
350
Actual
Start
Dec 15, 2009
Primary completion
May 3, 2012
Study completion May 3, 2012
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Jan 28, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prevention of invasive fungal infection in high risk patients following liver transplant.
Conditions
- Liver Transplantation
- Mycoses
Interventions
micafunginDrug
intravenous infusion
fluconazoleDrug
intravenous infusion
liposomal amphotericin BDrug
intravenous infusion
caspofunginDrug
intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- 'Clinical success' at the End of Prophylaxis as assessed by the Independent Data Review Board (IDRB).Time frame: up to 21 days
Locations
36 sites in 14 countries. Site status is shown where the registry gives one.
Site not named
Innsbruck, Austria
Site not named
Antwerp, Belgium
Site not named
Brussels, Belgium
Site not named
Brussels, Belgium
Site not named
Ghent, Belgium
Site not named
Clichy, France
Site not named
Paris, France
Site not named
Toulouse, France
Site not named
Paris, Villejuif Cedex, France
Site not named
Berlin, Germany
Site not named
Hamburg, Germany
Site not named
Hanover, Germany
Site not named
Heidelberg, Germany
Site not named
Budapest, Hungary
Site not named
Dublin, Ireland
Site not named
Milan, Italy
Site not named
Padova, Italy
Site not named
Torino, Italy
Site not named
Udine, Italy
Site not named
Coimbra, Portugal
Site not named
Porto, Portugal
Site not named
Bucharest, Romania
Site not named
Moscow, Russia
Site not named
Moscow, Russia
Site not named
Saint Petersburg, Russia
Site not named
Riyadh, Saudi Arabia
Site not named
Barcelona, Spain
Site not named
Córdoba, Spain
Site not named
Madrid, Spain
Site not named
Madrid, Spain
Site not named
Valencia, Spain
Site not named
Santiago de Compostela, A Coruna, Spain
Site not named
Barakald, Vicaya, Spain
Site not named
Stockholm, Sweden
Site not named
Birmingham, United Kingdom
Site not named
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.